Nirvana Life Sciences Inc.
NIRVF
$0.083
$0.0830.00%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.16% | -9.29% | 84.04% | -6,507.50% | 103.23% |
| Total Depreciation and Amortization | -- | -- | -- | -50.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -198.03% | 20,400.00% | -100.07% | 224.50% | -422.49% |
| Change in Net Operating Assets | 1,823.53% | -91.54% | -64.04% | 24.64% | 134.20% |
| Cash from Operations | 52.86% | -2,525.00% | 81.40% | 31.75% | 87.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -214.10% | 609.43% | 15.22% | 130.00% | -85.29% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -428.26% | 626.32% | 11.76% | 126.67% | -94.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 1,150.55% | -313.64% | -- | -- | -- |
| Net Change in Cash | -96.00% | -412.50% | 188.89% | 81.25% | 79.49% |